SCHEMBL3316191

SCHEMBL3316191

CNCCCNCCOC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
PKM P14618 1/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP2C19 P33261 3/20 0.38
GLA P06280 1/20 0.38
CYP1A2 P05177 2/20 0.36
RECQL P46063 1/20 0.35
EPHX1 P07099 1/20 0.35
HTR1B P28222 1/20 0.34
PAOX Q6QHF9 1/20 0.34
SAT1 P21673 1/20 0.34
ADRB2 P07550 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPK1 P28482 1/20 0.34
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
DRD3 P35462 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18508383 0.90 CYP2C19 (0.42) KDM4EALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL8327575 0.89 KDM4E (0.46) KDM4EALDH1A1PKMMEN1KMT2A
SCHEMBL18508384 0.85 KDM4E (0.44) KDM4EALDH1A1PKMMEN1KMT2A
SCHEMBL2253376 0.84
SCHEMBL11548639 0.83 EPHX1 (0.44) KDM4EALDH1A1PKMMEN1KMT2A
SCHEMBL6223853 0.81 ALDH1A1 (0.46) KDM4EALDH1A1PKMMEN1KMT2A
SCHEMBL3024820 0.81 CYP2C19 (0.53) ALDH1A1MEN1KMT2ACYP2C19GLA
SCHEMBL11119 0.81
SCHEMBL26367204 0.81 CYP2C19 (0.53) ALDH1A1MEN1KMT2ACYP2C19GLA
SCHEMBL25141638 0.80 MAPK1 (0.42) KDM4EALDH1A1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100104659-A1 BENZOPYRANOPYRAZOLES 4SC AG (DE) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100104659-A1 BENZOPYRANOPYRAZOLES BAX, BCL2, BAD KDM4E 2313/4885ALDH1A1 474/4885PKM 2679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.